Related Experiment Video

Updated: Sep 25, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing

Chang-Hung Chen1, Carole Seguin-Devaux, Nancy A Burke

  • 1Vion Pharmaceuticals, Incorporated, New Haven, CT 06511, USA.

The Journal of Experimental Medicine
|June 18, 2003
PubMed

Insights

Transforming growth factor-beta (TGF-β) limits T cell differentiation by inhibiting the Tec kinase Itk. This blocks calcium influx and downstream signaling essential for Th1 and Th2 cell development.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Transforming growth factor-beta (TGF-β) is known to inhibit T cell proliferation and differentiation.
  • TGF-β can suppress key transcription factors like GATA-3 and T-bet, crucial for T cell lineage commitment.

Purpose of the Study:

  • To investigate the proximal mechanisms by which TGF-β inhibits T cell differentiation.
  • To elucidate the role of Tec kinases in TGF-β-mediated regulation of T cell activation and differentiation.

Main Methods:

  • Stimulation of CD4+ T cells.
  • Analysis of Tec kinase (Itk) phosphorylation and activation.
  • Measurement of intracellular calcium (Ca2+) levels.
  • Assessment of NFATc translocation and ERK activation.

Main Results:

  • TGF-β inhibits the phosphorylation and activation of the Tec kinase Itk in stimulated CD4+ T cells.
  • TGF-β treatment leads to reduced intracellular Ca2+ influx.
  • Inhibition of NFATc translocation and ERK activation was observed under TGF-β treatment.
  • These molecular events collectively impair T cell differentiation.

Conclusions:

  • TGF-β acts at a proximal step to inhibit T cell differentiation by targeting Itk kinase.
  • Inhibition of Itk and subsequent Ca2+ influx by TGF-β restricts both Th1 and Th2 lineage differentiation.

More Related Videos

Preparing T Cell Growth Factor from Rat Splenocytes18:27

Preparing T Cell Growth Factor from Rat Splenocytes

Published on: October 31, 2007

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...